|
⚲
|
| Larry Dillaha | |
|---|---|
| Firm | |
| Address | 5511 Virginia Way Suite 300 Brentwood, TN 37027 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Melt Pharmaceuticals Inc | 021-489452 | Executive Officer | 42.3 M of 47.8 M |
||
| Melt Pharmaceuticals Inc | 021-332805 | Director | 11.4 M of 25.8 M |
||
| New Haven Pharmaceuticals Inc | 021-269056 | Director | 0.6 M of 1.3 M |
||
| Affinimark Technologies Inc | 021-258481 | Executive Officer | 1.6 M of 1.6 M |
||
| New Haven Pharmaceuticals Inc | 021-227000 | Director | 11.8 M of 21.8 M |
||
| New Haven Pharmaceuticals Inc | 021-184919 | Director | 6.5 M of 7.7 M |
||
| Insys Therapeutics Inc | 021-158053 | Executive Officer | 2.3 M of 2.3 M |
||
| Invasc Therapeutics Inc | 021-144812 | Director | 3.2 M of 12.0 M |
||